GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was £7.74B, up 18.1% from the year before. Over ten years it grew 11.7% a year on average. The highest annual figure on record is £8.44B in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | £7.74B | +18.1% |
| FY2024 | Dec 31, 2024 | £6.55B | -3.2% |
| FY2023 | Dec 31, 2023 | £6.77B | -8.6% |
| FY2022 | Dec 31, 2022 | £7.40B | -6.9% |
| FY2021 | Dec 31, 2021 | £7.95B | -5.8% |
| FY2020 | Dec 31, 2020 | £8.44B | +5.2% |
| FY2019 | Dec 31, 2019 | £8.02B | -4.8% |
| FY2018 | Dec 31, 2018 | £8.42B | +21.7% |
| FY2017 | Dec 31, 2017 | £6.92B | +6.5% |
| FY2016 | Dec 31, 2016 | £6.50B | +152.9% |
| FY2015 | Dec 31, 2015 | £2.57B | – |